Insider trades
Douglas Doerfler, CEO of Maxcyte MXCT, has filed 0 purchases and 23 sales on the open market. The latest trade was on 23/12/05.
Douglas Doerfler
President and CEO
- Company
- Maxcyte MXCT
- First filing
- 23/01/05
- Trades
- 70 trades
- Buys / sales
- 0 / 23
- 12-month net buying
- No record
- Last trade
- 23/12/05
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
MXCT | Open-market sale | 23/12/04–23/12/05 | 23/12/06 | 124,450 sh2 trades | $5.14avg. | $639,405.22 | −27.2% |
MXCT | Open-market sale | 23/11/29–23/12/01 | 23/12/01 | 25,550 sh2 trades | $5.00avg. | $127,750 | −7.1% |
MXCT | Open-market sale10b5-1 plan | 23/07/10–23/07/12 | 23/07/12 | 30,000 sh3 trades | $5.03avg. | $150,851.51 | −8.3% |
MXCT | Open-market sale10b5-1 plan | 23/06/13–23/06/14 | 23/06/15 | 43,851 sh2 trades | $5.04avg. | $220,859.36 | −11.6% |
MaxcyteMXCT | Open-market sale10b5-1 plan | 23/05/03 | 23/05/05 | 16,149 sh | $5.02 | $81,067.98 | −4.6% |
MXCT | Open-market sale10b5-1 plan | 23/04/10–23/04/12 | 23/04/12 | 15,000 sh3 trades | $5.00avg. | $75,000 | −4.3% |
MXCT | Open-market sale10b5-1 plan | 23/04/05–23/04/06 | 23/04/07 | 34,823 sh2 trades | $5.02avg. | $174,950.86 | −9.5% |
MXCT | Open-market sale10b5-1 plan | 23/03/31–23/04/04 | 23/04/04 | 10,177 sh3 trades | $5.02avg. | $51,110.1 | −3.0% |
MXCT | Open-market sale | 23/02/01–23/02/02 | 23/02/03 | 30,000 sh2 trades | $5.72avg. | $171,553.2 | −8.3% |
MXCT | Open-market sale | 23/01/03–23/01/05 | 23/01/05 | 30,000 sh3 trades | $5.08avg. | $152,429.76 | −8.3% |